Ultralife Corporation
ULBI
$9.14
-$0.01-0.11%
| Weiss Ratings | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | B | |||
| Rating Factors | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.83 | |||
| Price History | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.11% | |||
| 30-Day Total Return | -13.36% | |||
| 60-Day Total Return | -22.28% | |||
| 90-Day Total Return | -21.48% | |||
| Year to Date Total Return | 37.86% | |||
| 1-Year Total Return | -7.49% | |||
| 2-Year Total Return | 82.07% | |||
| 3-Year Total Return | 28.91% | |||
| 5-Year Total Return | 12.15% | |||
| 52-Week High % Change | -31.67% | |||
| 52-Week Low % Change | 43.87% | |||
| Price | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $13.39 | |||
| 52-Week Low Price | $6.36 | |||
| 52-Week Low Price (Date) | Jan 08, 2024 | |||
| 52-Week High Price (Date) | May 09, 2024 | |||
| Valuation | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 152.10M | |||
| Enterprise Value | 161.83M | |||
| Price/Earnings (TTM) | 15.16 | |||
| Earnings Per Share (TTM) | 0.60 | |||
| Earnings Per Share Growth | 300.60% | |||
| Price/Earnings To Growth | 0.05 | |||
| Price/Sales (TTM) | 0.91 | |||
| Price/Book (Q) | 1.14 | |||
| Enterprise Value/Revenue (TTM) | 0.96 | |||
| Price | $9.14 | |||
| Enterprise Value/EBITDA (TTM) | 9.14 | |||
| Enterprise Value/EBIT | 11.76 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 16.83M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 315 332 7100 | |||
| Address | 2000 Technology Parkway Newark, NY 14513 | |||
| Website | www.ultralifecorporation.com | |||
| Country | United States | |||
| Year Founded | 1990 | |||
| Profitability | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 8.14% | |||
| Profit Margin | 5.95% | |||
| Management Effectiveness | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.98% | |||
| Return on Equity | 7.94% | |||
| Income Statement | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 168.95M | |||
| Total Revenue (TTM) | 168.95M | |||
| Revenue Per Share | $10.04 | |||
| Gross Profit (TTM) | 44.21M | |||
| EBITDA (TTM) | 17.70M | |||
| EBIT (TTM) | 13.76M | |||
| Net Income (TTM) | 10.06M | |||
| Net Income Avl. to Common (TTM) | 10.06M | |||
| Total Revenue Growth (Q YOY) | 0.68% | |||
| Earnings Growth (Q YOY) | -10.60% | |||
| EPS Diluted (TTM) | 0.60 | |||
| EPS Diluted Growth (Q YOY) | -13.39% | |||
| Balance Sheet | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 6.69M | |||
| Cash Per Share (Q) | $0.40 | |||
| Total Current Assets (Q) | 83.79M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 133.35M | |||
| Current Ratio (Q) | 4.073 | |||
| Book Value Per Share (Q) | $8.01 | |||
| Total Assets (Q) | 169.82M | |||
| Total Current Liabilities (Q) | 20.57M | |||
| Total Debt (Q) | 16.28M | |||
| Total Liabilities (Q) | 36.47M | |||
| Total Common Equity (Q) | 133.21M | |||
| Cash Flow | ULBI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.27M | |||
| Cash from Financing (TTM) | -9.62M | |||
| Net Change in Cash (TTM) | -1.59M | |||
| Levered Free Cash Flow (TTM) | 3.35M | |||
| Cash from Operations (TTM) | 10.39M | |||
